L.E. Harrington

Materials Science · Physical Sciences

19h-index1.4kcitations118works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Crystallization and Solubility Studies(65), X-ray Diffraction in Crystallography(65), Angiogenesis and VEGF in Cancer(18), Cancer Treatment and Pharmacology(15), Organometallic Complex Synthesis and Catalysis(12)

Publications118 total

Earnings Management and Financial Sustainability: A Comparative Study of Distressed and Non-Distressed Firms in the GCC
2025Open Access
Outcome of Ayurvedic Orthopaedic Protocol (Asthi Chikitsā) in closed tibial fractures: A clinical study
Journal of Shalya and Shalakya Vigyan·2025Open Access
Supplementary Table S3 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Data from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Table S1 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Table S2 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Data from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Table S1 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023· 1 citedOpen Access
Supplementary Table S4 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Fig. S2 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Table S3 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Fig. S1 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Table S2 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Fig. S1 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Table S4 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
Supplementary Fig. S2 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
2023Open Access
CCDC 1979614: Experimental Crystal Structure Determination
The Cambridge Structural Database·2020Open Access
CCDC 1492571: Experimental Crystal Structure Determination
The Cambridge Structural Database·2018Open Access
CCDC 1492572: Experimental Crystal Structure Determination
The Cambridge Structural Database·2018Open Access
CCDC 1492570: Experimental Crystal Structure Determination
The Cambridge Structural Database·2018Open Access
page 1 of 6Next →

Frequent Co-authors

Michael J. McGlinchey(21), James F. Britten(16), Y. Ortin(10), David J. H. Emslie(8), Teresa M. Hopper(7), James A. Onori(7), Andrea H. Epperly(7), Jeffrey A. Stafford(7), Mui Cheung(7), Helge Müller‐Bunz(7), James F. Britten(7), Jennifer H. Johnson(6), Renae M. Crosby(6), Charles G. Miller(6), Robert J. Mullin(6), Tona M. Gilmer(6), Deirdre K. Luttrell(6), E.V. Banide(6), C. Seward(6), Victoria B. Knick(5)